Progamme:

SYMPOSIUM OF THE BELGIAN SOCIETY FOR CLINICAL NEUROPHYSIOLOGY & BELGIAN NEUROLOGICAL SOCIETY.

PART I: Parallel sessions 8h30 – 10h00*:

*Each session (45 min.) is held twice. Participants can choose 2 subsequent sessions from:

• EEG abnormalities in clinical practice

– Speaker: S. Ferrao Santos (UCLouvain) – Chair: A. Fierain (CHN Lennox).

• Artificial intelligence in neurology

– Speaker: R. Bruffaerts (UA/UZA) – Chair: D. Smeets (Icometrix).

• Introduction to Intra-operative neurophysiological monitoring

– Speakers: T. Reynders (UZA) & C. Timmermans (ZOL) – Chair: D. Dive (ULiège).

• EMG training: learning to trust your ears

– Speaker: V. Bissay (VUB) – Chair: K. Verhoeven (AZ Brugge, UZ Gent).

• Advanced EMG techniques: single fiber EMG and cranial nerves

– Speaker: Joke Terryn (UZ Leuven) – Chair: Olivier Stevens (UZ Leuven).

 

Coffee break 10h00 – 10h30.

 

Opening of the main program – B. Hanseeuw and N. Gaspard 10h30 – 10h40.

PART II: Plenary sessions – Chair: N. Gaspard.

• Critical Care EEG: past, present, and future 10h40 – 11h20

– Lawrence Hirsch (Yale, US).

• MEG as a platform for early phase clinical trial in dementia 11h20 – 12h00

– Laura Hughes (Cambridge, UK).

PART III: BBVN/UPBN session – Chair: Dr.  L. Vanopdenbosch

• “What’s new in reimbursement?” – L. Dobbels (Imelda, Bonheiden) 12h00 – 12h30.

PART IV: Sponsored satellite symposium – Chair: B. Hanseeuw 12h30 – 13h30.

• Argenx – “Vyvgart (efgartigimod alfa) in generalized Myasthenia Gravis: from clinical development to clinical experience”

• Alnylam -“hATTR amyloidosis: What the neurologist should know and how the NMRC expert can help your patients further if you do.”

 

Lunch 13h30 – 14h30